We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
NovaBay Pharmaceuticals Inc New | AMEX:NBY | AMEX | Common Stock |
Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|
-0.0007 | -0.78% | 0.0889 | 0.0901 | 0.085 | 0.0892 | 518,205 | 20:05:22 |
Delaware
|
001-33678
|
68-0454536
|
(State or Other Jurisdiction
of Incorporation)
|
(Commission File Number)
|
(I.R.S. Employer
Identification No.)
|
Title of Each Class
|
Trading Symbol(s)
|
Name of Each Exchange On Which Registered
|
||
Common Stock, par value $0.01 per share
|
NBY
|
NYSE American
|
☐
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
☐
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
☐
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
☐
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Nominee
|
For
|
Withhold
|
Broker Non-Votes1
|
Paul E. Freiman
|
15,237,888
|
2,546,176
|
11,927,195
|
Swan Sit
|
16,035,062
|
1,749,002
|
11,927,195
|
For
|
Against
|
Abstain
|
Broker Non-Votes1
|
15,641,081
|
1,876,704
|
266,279
|
11,927,195
|
For
|
Against
|
Abstain
|
28,459,788
|
1,075,415
|
176,056
|
NovaBay Pharmaceuticals, Inc.
|
||
By:
|
/s/ Justin Hall
|
|
Justin Hall
|
||
Chief Executive Officer and General Counsel
|
1 Year NovaBay Pharmaceuticals Chart |
1 Month NovaBay Pharmaceuticals Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions